SCCA
Showing 1 - 25 of 66
Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis
Completed
- Psoriasis
- Blood samples
-
Tours, FranceDermatology Service, University Hospital, Tours
May 30, 2022
Squamous Cell Carcinoma antigen2 in Verruca Vulgaris
Recruiting
- Verruca Vulgaris
- Healthy
- Immunohistochemical staining monoclonal antibodies to SCCA2 (SERPINB4/ SCCA2 antibody)
-
Sohag, EgyptSohag University
Jun 7, 2022
Oropharyngeal Squamous Cell Carcinoma, Supraglottic Squamous Cell Carcinoma Trial in Charlottesville (Transoral robotic surgery)
Active, not recruiting
- Oropharyngeal Squamous Cell Carcinoma
- Supraglottic Squamous Cell Carcinoma
- Transoral robotic surgery
-
Charlottesville, VirginiaUniversity of Virginia Health System
Nov 20, 2022
PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark
Recruiting
- Anal Cancer
-
Aarhus, Denmark
- +2 more
Oct 5, 2022
Esophagus Cancer, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (radiation, drug, other, procedure)
Recruiting
- Esophagus Cancer
- +2 more
- Intensity Modulated Radiation Therapy
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 6, 2022
Metastatic Colorectal Cancer Trial in Duarte, St Leonards (Magrolimab, Bevacizumab, Irinotecan)
Recruiting
- Metastatic Colorectal Cancer
- Magrolimab
- +4 more
-
Duarte, California
- +19 more
Jan 27, 2023
Soft Tissue Sarcoma Adult Trial in Lake Success, Portland, Seattle (Multiple drug microinjection, CIVO device)
Completed
- Soft Tissue Sarcoma Adult
- Multiple drug microinjection
- CIVO device
-
Lake Success, New York
- +2 more
Sep 22, 2021
Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,
Terminated
- Mycosis Fungoides
- +2 more
- Naloxone Hydrochloride Lotion, 0.5%
- Placebo Lotion
-
Little Rock, Arkansas
- +15 more
Oct 26, 2022
Hepatocellular Cancer, AFP Expressing Tumors Trial in Worldwide (Autologous genetically modified AFP?³³²T cells)
Active, not recruiting
- Hepatocellular Cancer
- AFP Expressing Tumors
- Autologous genetically modified AFPᶜ³³²T cells
-
Phoenix, Arizona
- +20 more
Aug 26, 2022
Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,
Active, not recruiting
- Castration-resistant Prostate Cancer
- +2 more
- SM08502
- +5 more
-
Tucson, Arizona
- +19 more
Oct 18, 2022
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell
Active, not recruiting
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- +2 more
- Computed Tomography
- +7 more
-
Seattle, Washington
- +1 more
Jul 18, 2022
Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane
Recruiting
- Metastatic Breast Cancer
- Enobosarm & Abemaciclib Combo
- non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
-
Chandler, Arizona
- +29 more
Feb 1, 2023
Patients With Anal Cancer Treated With Induction Chemotherapy
Recruiting
- Anal Cancer
- +4 more
-
Aarhus, Aarhus N, Denmark
- +2 more
Feb 9, 2022
Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)
Completed
- Recurrent Squamous Cell Lung Carcinoma
- Stage IV Squamous Cell Lung Carcinoma AJCC V7
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2021
Anal Cancer Trial in Worldwide (AMR B: HPV positive ctDNA guided imaging in follow-up)
Not yet recruiting
- Anal Cancer
- AMR B: HPV positive ctDNA guided imaging in follow-up
-
Herlev, Capital Region Of Denmark, Denmark
- +12 more
Oct 5, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +20 more
- Chimeric Antigen Receptor T-Cell Therapy
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 11, 2022
Research in Patients With Squamous Cell Anal Carcinoma
Withdrawn
- Anal Canal Cancer
- Additional biological samples
-
Besançon, France
- +1 more
Jul 26, 2021
Breast Carcinoma, Colon Carcinoma, Malignant Solid Tumor Trial in Sequim (Electronic Health Record Review, Questionnaire
Completed
- Breast Carcinoma
- +5 more
- Electronic Health Record Review
- +2 more
-
Sequim, WashingtonOlympic Medical Cancer Center
Jan 4, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle
Recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +8 more
- Cyclophosphamide
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 30, 2022
Squamous Cell Anal Carcinoma, Metastatic Squamous Cell Carcinoma Trial in Besançon, Lyon, Montbeliard (Sample collection)
Recruiting
- Squamous Cell Anal Carcinoma
- Metastatic Squamous Cell Carcinoma
- Sample collection
-
Besançon, France
- +2 more
Mar 10, 2022
Metastatic Colorectal Cancer Trial in Worldwide (Xilonix, Placebo)
Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma Trial in United States (CMB305, atezolizumab)
Terminated
- Sarcoma
- +6 more
- CMB305
- atezolizumab
-
Palo Alto, California
- +17 more
Jun 26, 2020